Interventions for acute non-arteritic central retinal artery occlusion

Cochrane Database of Systematic Reviews

Volumn , Issue 1, 2009, Pages

  Fraser, Scott G ^a   Adams, Wendy ^a  

^a SUNDERLAND EYE INFIRMARY   (United Kingdom)

Author keywords

Acute disease; Counterpulsation methods ; Hemodilution methods ; Humans; Pentoxifylline therapeutic use ; Randomized controlled trials as topic; Retinal artery occlusion *therapy ; Vasodilator agents therapeutic use

Indexed keywords

PENTOXIFYLLINE; STEROID;

CENTRAL RETINA ARTERY OCCLUSION; CLINICAL ASSESSMENT; CLINICAL RESEARCH; CLINICAL TRIAL; COCHRANE LIBRARY; COMPARATIVE STUDY; CONTROL GROUP; CONVALESCENCE; COUNTERPULSATION; DATA ANALYSIS; DATA EXTRACTION; DATA SYNTHESIS; EMBASE; HEALTH CENTER; HEMODILUTION; HUMAN; INFORMATION PROCESSING; INTERVENTION STUDY; INTRAOCULAR PRESSURE; MASSAGE; MEDLINE; OUTCOME ASSESSMENT; PERFUSION; POPULATION; RETINA; REVIEW; RISK; RISK ASSESSMENT; SENSITIVITY ANALYSIS; TABLET; THERAPY EFFECT; UNSPECIFIED SIDE EFFECT; VASCULARIZATION; VISION;

EID: 70249085527     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD001989.pub2     Document Type: Review

References (39)

1. Incandela L, Cesarone MR, Belcaro G, Steigerwalt R, De Sanctis MT, Nicolaides AN, et al.Treatment of vascular retinal disease with pentoxifylline: a controlled, randomized trial. Angiology 2002;53 (Suppl 1):S31-4. (Pubitemid 34145916)
2. Werner D, Michalk F, Harazny J, Hugo C, Daniel WG, Michelson G. Accelerated reperfusion of poorly perfused retinal areas in central retinal artery occlusion and branch retinal artery occlusion after a short treatment with enhanced external counterpulsation. Retina 2004;24(4):541-547 (Pubitemid 39079878)
3. Arnold M, Koerner U, Remonda L, Nedeltchev K, Mattle HP, Schroth G, et al.Comparison of intra-arterial thrombolysis with conventional treatment in patients with acute central retinal artery occlusion. Journal of Neurology, Neurosurgery & Psychiatry 2005;76(2): 196-199 (Pubitemid 40143707)
4. Atebara NH, Brown GC, Cater J. Efficacy of anterior chamber paracentesis and Carbogen in treating acute nonarteritic central retinal artery occlusion. Ophthalmology 1995;102(12):2029-2034 (Pubitemid 26004464)
5. Augsburger JJ, Magargal LE. Visual prognosis following treatment of acute central retinal artery obstruction. British Journal of Ophthal- mology 1980;64(12):913-917
6. Drago F, Amico-Roxas M, Matera M. Effects of L-acetyl-carnitine on the electroretinographic responses in patients with central retinal artery occlusion. Acta Therapeutica 1982;8(3):201-208 (Pubitemid 13235369)
7. Gu WZ, Pu RX, Wang YG, Zhou LX, Dong L, Liu H. Analysis on the curative effects of GEQI oral in treatment of retinal artery occlusion. Aerospace Medicine 1999;10(2):64-66
8. Holschermann H, Krombach C, Jung A, Jacobi F, Tillmanns H, Weinand F. Treatment of acute central retinal artery occlusion with the platelet glycoprotein IIb/IIIa receptor inhibitor tirofiban. Throm- bosis & Haemostasis 2005;94(3):684-686 (Pubitemid 41300873)
9. Iwafune Y, Yoshimoto H. Clinical use of pentoxifylline in haemorrhagic disorders of the retina. Pharmatherapeutica 1980;2(7):429-438 (Pubitemid 11207051)
10. Kattah JC, Wang DZ, Reddy C. Intravenous Recombinant Tissue- Type Plasminogen Activator Thrombolysis in Treatment of Central Retinal Artery Occlusion. Archives of Ophthalmology 2002;120(9): 1234-1236 (Pubitemid 35034356)
11. Neubauer AS, Mueller AJ, Schriever S, Gruterich M, Ulbig M, Kampik A. Minimally invasive therapy for clinically complete central retinal artery occlusion - results and meta-analysis of literature [Minimal invasive Therapie bei klinisch komplettem Zentralarterienverschluss - eigene Ergebnisse und Literaturvergleich]. Klinische Monatsblatter fur Augenheilkunde 2000;217(1):30-36
12. Pettersen JA, Hill MD, Demchuk AM, Morrish W, Hudon ME, Hu W, et al.Intra-arterial thrombolysis for retinal artery occlusion: the Calgary experience. Canadian Journal of Neurological Sciences 2005; 32(4):507-511 (Pubitemid 41788912)
13. Richard G, Lerche RC, Knospe V, Zeumer H. Treatment of retinal arterial occlusion with local fibrinolysis using recombinant tissue plasminogen activator. Ophthalmology 1999;106(4):768-773 (Pubitemid 30194321)
14. Rumelt S, Dorenboim Y, Rehany U. Aggressive systematic treatment for central retinal artery occlusion. American Journal of Ophthalmol- ogy 1999;128(6):733-738 (Pubitemid 30001769)
15. Schmidt D, Schumacher M, Wakhloo AK. Microcatheter urokinase infusion in central retinal artery occlusion. American Journal of Oph- thalmology 1992;113(4):429-434
16. Schumacher M, Schmidt D, Wakhloo AK. Intra-arterial fibrinolytic therapy in central retinal artery occlusion. Neuroradiology 1993;35 (8):600-605 (Pubitemid 23315735)
17. Weber J, Remonda L, Mattle HP, Koerner U, Baumgartner RW, Sturzenegger M, et al.Selective intra-arterial fibrinolysis of acute central retinal artery occlusion. Stroke 1998;29(10):2076-2079 (Pubitemid 28443521)
18. Arora RR, Chou TM, Jain D, Fleishman B, Crawford L, McKiernan T, et al.Themulticenter study of enhanced external counterpulsation (MUST-EECP): effect of EECP on exercise-induced myocardial ischemia and anginal episodes. Journal of the American College of Car- diology 1999;33(7):1833-1840
19. Bath PMW, Bath-Hextall FJ. Pentoxifylline, propentofylline and pentifylline for acute ischaemic stroke. Cochrane Database of Sys- tematic Reviews 2004, Issue 3. [Art. No.: CD000162. DOI: 10.1002/14651858.CD000162.pub2]
20. Beatty S, Au Eong KG. Local intra-arterial fibrinolysis for acute occlusion of the central retinal artery: a meta-analysis of the published data. British Journal of Ophthalmology 2000;84(8):914-916 (Pubitemid 30599103)
21. Brown GC. Retinal arterial obstructive disease. In: Ryan SJ editor (s). Retina. 2nd Edition. Philadelphia: CVMosby Co, 1994:1361-1377
22. Deutsch TA, Read JS, Ernest JT, Goldstick TK. Effects of oxygen and carbon dioxide on the retinal vasculature in humans. Archives of Ophthalmology 1983;101(8):1278-1280
23. Feltgen N, Neubauer A, Jurklies B, Schmoor C, Schmidt D, Wanke J, et al.Multicenter study of the European Assessment Group for Lysis in the Eye (EAGLE) for the treatment of central retinal artery occlusion: design issues and implications. EAGLE Study report no.1 : EAGLE Study report no. 1. Graefes Archive for Clinical and Experimental Ophthalmology 2006;244(8):950-956 (Pubitemid 44184499)
24. Ffytche TJ. A rationalization of treatment of central retinal artery occlusion. Transactions of the Ophthalmological Societies of the United Kingdom 1974;94(2):468-479
25. Frampton JE, Brogden RN. Pentoxifylline (oxpentifylline). A review of its therapeutic efficacy in the management of peripheral vascular and cerebrovascular disorders. Drugs Aging 1995;7(6):480-503.
26. Glanville JM, Lefebvre C, Miles JN, Camosso-Stefinovic J. How to identify randomized controlled trials in MEDLINE: ten years on. Journal of the Medical Library Association 2006;94(2):130-136
27. Harino S, Grunwald JE, Petrig BJ, Riva CE. Rebreathing into a bag increases human retinal macular blood velocity. British Journal of Ophthalmology 1995;79(4):380-383
28. Harvey PA, Winder S, Talbot JF. Trabeculectomy for central retinal artery occlusion. Eye 2000;14(Pt 2):256-257 (Pubitemid 30265186)
29. Hausmann N, Richard G. Effect of high dose steroid bolus on occlusion of ocular central artery: angiographic study. BMJ 1991;303 (6815):1445-1446
30. Hayreh SS, Kolder HE, Weingeist TA. Central retinal artery occlusion and retinal tolerance time. Ophthalmology 1980;87(1):75-78 (Pubitemid 10196118)
31. Higgins JPT, Altman DG (editors). Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.0 (updated February 2008). The Cochrane Collaboration, 2008. Available from www.cochrane-handbook.org.
32. Kieswetter H, Korber N, Jung F, Reim M. Rheologic findings in patients with acute central retinal artery occlusion. Graefe's Archive for Clinical and Experimental Ophthalmology 1983;220(2):92-95
33. Manchanda A, Soran O. Enhanced external counterpulsation and future directions: step beyondmedicalmanagement for patients with angina and heart failure. Journal of the American College of Cardiology 2007;50(16):1523-1531 (Pubitemid 47532332)
34. Pettersson T, Bondesson S, Cojocaru D, Ohlsson O, Wackenfors A, Edvinsson L. One year follow-up of patients with refractory angina pectoris treated with enhanced external counterpulsation. BMC Car- diovascular Disorders 2006;6:28. (Pubitemid 44123462)
35. Rassam SM, Patel V, Kohner EM. The effect of acetazolamide on the retinal circulation. Eye 1993;7(Pt 5):697-702.
36. Sandercock P, Gubitz G, Foley P, Counsell C. Antiplatelet therapy for acute ischaemic stroke. Cochrane Database of Systematic Reviews 2003, Issue 2. [DOI: 10.1002/14651858.CD000029]
37. Schmetterer L, Lexer F, Findl O, Graselli U, Eichler HG, Wolzt M. The effect of inhalation of different mixtures of O2 and CO2 on ocular fundus pulsations. Experimental Eye Research 1996;63(4): 351-355 (Pubitemid 26366762)
38. Wardlaw JM, del Zoppo G, Yamaguchi T, Berge E. Thrombolysis for acute ischaemic stroke. Cochrane Database of System- atic Reviews 2003, Issue 3. [Art. No.: CD000213. DOI: 10.1002/14651858.CD000213]
39. Fraser S, Siriwardena D. Interventions for acute non-arteritic central retinal artery occlusion. Cochrane Database of Systematic Reviews 2002, Issue 1. [DOI: 10.1002/14651858.CD001989] * Indicates the major publication for the study